A prospective analysis of the accuracy of [68Ga]Ga-PSMA-11 PET/CT by Hofman et al. revealed an overall sensitivity of 85% (vs. 38%) and a specificity of 98% (vs. 91%), outperforming conventional imaging in prostate cancer (bone scan/CT) [54]. Here, FOLH1 is linked to prostate cancer.